🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The current study aims to assess the effect of an 8 week Azilect treatment ...
Status
Unknown
Location
St. Josef Hospital
Start Date
2011-10
Trial ID
NCT01385735
Treatments Being Tested
The purpose of this study is to find out if rasagiline improves RLS symptom...
Status
Terminated
Location
Advent Research
Start Date
2010-09
Trial ID
NCT01192503
Treatments Being Tested
This is a non-randomized, dose-escalation first-in-human study to evaluate ...
Status
Completed
Location
Frontage Clinical Services, Inc.
Start Date
2022-08-22
Trial ID
NCT05523570
This study will investigate the effects of a contingency-based musical walk...
Status
Unknown
Location
Pacific Parkinson's Research Centre
Start Date
2013-10
Trial ID
NCT02207387
This study is to determine if Tyramine has any side effects on patients rec...
Status
Completed
Location
Multiple Locations
Start Date
2000-10
Trial ID
NCT00203125
Treatments Being Tested
This is a study to look at the effectiveness, tolerability, and safety of o...
Status
Completed
Location
Margolin Brain Institute
Start Date
2002-05
Trial ID
NCT00203164
Treatments Being Tested
Study for patients currently using Levodopa/Carbidopa who will be assigned ...
Status
Completed
Location
Rush - Presbyterian St. Luke's Medical Center
Start Date
2000-05
Trial ID
NCT00203034
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and effi...
Status
Completed
Location
Collaborative Neuroscience Network
Start Date
2004-08
Trial ID
NCT00104273
Treatments Being Tested
The purpose of this survey is to evaluate the long-term safety of Rasagilin...
Status
Completed
Location
Takeda Selected Site
Start Date
2018-11-01
Trial ID
NCT03727139
Treatments Being Tested
End-of-dose fluctuations e. g. wearing-off are defined as a recurrence of m...
Status
Completed
Location
Teva Investigational Sites
Start Date
2014-01
Trial ID
NCT02384512
Treatments Being Tested